We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Xi'an Tianlong Science & Technology Co., Ltd

Tianlong is an innovative, high-technology company that provides professional PCR detection devices, reagent kits and... read more Featured Products: More products

Download Mobile App




Tianlong’s PCR Lab Solution Safeguards 2022 G20 Indonesia Summit

By LabMedica International staff writers
Posted on 03 Jan 2023
Print article
Image: Tianlong`s PCR lab solution provided protection at the G20 summit in 2022 in Indonesia (Photo courtesy of Tianlong)
Image: Tianlong`s PCR lab solution provided protection at the G20 summit in 2022 in Indonesia (Photo courtesy of Tianlong)

Tianlong Science and Technology (Shaanxi, China) safeguarded a successful G20 summit in 2022 in Indonesia, which has been one of the company’s largest overseas markets. Before the G20 summit, Tianlong's PCR lab solution was applied in several healthcare centers locally, including the Jakarta international airport. The company’s solution helps conduct nucleic acid testing for inbound and outbound passengers, and protected the gateway to Indonesia during the COVID-19 phase.

Tianlong’s star products – the Gentier 96 Real-Time PCR system and Libex nucleic acid extractor – have received high praise from clients in Indonesia due to their high efficiency and stable quality. The Gentier 96E/96R real-time fluorescence quantitative PCR detection system is tailored to meet the needs of high-end users. The product has many advantages, such as a scientific and efficient temperature control system and photoelectric system, powerful and easy-to-use software analysis function, humanized control mode, etc., and can easily realize the application of downstream multiple gene detection, quantitative analysis, SNP analysis, fusion curve analysis and so on. It is widely used in medical institutions, universities and research institutes, CDC, exit inspection and Quarantine Bureau, public security criminal investigation and material evidence identification center, veterinary station, food enterprises and dairy products factories.

Tianlong’s Libex nucleic acid extractor, which is based on the automated extraction method of magnetic bead adsorption separation, overcomes the shortcomings of conventional nucleic acid extraction methods and achieve rapid and efficient sample preparation. With the appropriate nucleic acid extraction reagents, it can process serum, plasma, whole blood, swabs, amniotic fluid, feces, tissue and tissue lavage, paraffin sections, bacteria, fungi and other sample types. The Libex nucleic acid extractor is widely used in the fields of disease prevention and control, animal quarantine, clinical diagnosis, entry-exit inspection and quarantine, food and drug administration, forensic medicine, teaching and scientific researches.

Tianlong continues to innovate to make better products and offer better services to its customers worldwide. The company continues to cooperate with its clients and jointly develop better solutions for the global markets.

Related Links:
Tianlong Science and Technology

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Hemoglobin Testing System
VARIANTnbs

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.